Virtual

As we prepare for upcoming changes in 2026, the webinar will provide clarity on the purpose and evolving standards of the RFI, its connection to payer-provider relationships and its integration with CIBMTR data.

This webinar consists of two 30-minute journal club presentations, each including 20 minutes for the presentation and 10 minutes for discussion and a Q&A session. In the September Journal Club session, Drs. Yi and Trinh will present two articles related to 1) enhanced CAR T-cell therapy for lymphoma after previous failure and 2) linvoseltamab for the treatment of relapsed/refractory multiple myeloma.

This webinar is the first in a two-part CAR T webinar series and will highlight two talks from the 2025 Tandem Meetings.

This interactive webinar will highlight key research abstracts featured at the 2025 Tandem Meetings of ASTCT and CIBMTR.